CRIS Current Research Information System

BELLUZZI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.777
EU - Europa 3.410
AS - Asia 3.383
SA - Sud America 202
AF - Africa 200
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 4
Totale 10.992
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.715
IT - Italia 1.339
SG - Singapore 977
VN - Vietnam 923
CN - Cina 673
SE - Svezia 449
GB - Regno Unito 396
DE - Germania 285
HK - Hong Kong 261
FR - Francia 172
IN - India 159
BR - Brasile 149
RU - Federazione Russa 148
IE - Irlanda 132
NL - Olanda 111
UA - Ucraina 71
KR - Corea 70
JP - Giappone 66
CI - Costa d'Avorio 59
CH - Svizzera 52
BG - Bulgaria 48
TG - Togo 48
JO - Giordania 43
FI - Finlandia 42
CA - Canada 39
ZA - Sudafrica 39
PH - Filippine 34
AT - Austria 29
AR - Argentina 27
EE - Estonia 26
BE - Belgio 24
ES - Italia 22
ID - Indonesia 20
SC - Seychelles 20
TH - Thailandia 20
BD - Bangladesh 18
TW - Taiwan 17
AU - Australia 16
TR - Turchia 16
IR - Iran 13
PL - Polonia 13
SA - Arabia Saudita 11
GR - Grecia 10
IQ - Iraq 10
MX - Messico 10
MY - Malesia 10
PK - Pakistan 9
BH - Bahrain 8
CL - Cile 8
RO - Romania 8
LT - Lituania 7
NG - Nigeria 7
KE - Kenya 6
UZ - Uzbekistan 6
CO - Colombia 5
EC - Ecuador 5
HR - Croazia 5
ET - Etiopia 4
HN - Honduras 4
HU - Ungheria 4
MA - Marocco 4
MU - Mauritius 4
BA - Bosnia-Erzegovina 3
BZ - Belize 3
EG - Egitto 3
LB - Libano 3
NP - Nepal 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
DK - Danimarca 2
DZ - Algeria 2
EU - Europa 2
IL - Israele 2
LV - Lettonia 2
LY - Libia 2
PE - Perù 2
PS - Palestinian Territory 2
PT - Portogallo 2
SM - San Marino 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
CR - Costa Rica 1
CU - Cuba 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
IS - Islanda 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UY - Uruguay 1
Totale 10.989
Salva come PNG Salva come JPEG
Città #
Singapore 697
Ashburn 430
Chandler 408
Southend 313
Fairfield 246
Hong Kong 245
Houston 239
Ho Chi Minh City 216
Hanoi 214
Santa Clara 180
San Jose 170
Bologna 159
Dublin 126
Princeton 123
Seattle 123
Beijing 107
Ann Arbor 105
Woodbridge 102
Boardman 92
Cambridge 86
Wilmington 85
Milan 78
Hefei 77
Rome 76
Los Angeles 69
Lauterbourg 60
Abidjan 59
Seoul 54
Berlin 51
Tokyo 50
Dong Ket 49
Lomé 48
New York 44
Sofia 43
Amman 42
Buffalo 38
Bern 34
Dallas 31
Helsinki 31
Nanjing 31
Turin 31
Frankfurt am Main 30
Westminster 30
Haiphong 28
Padova 26
Council Bluffs 25
Da Nang 23
Falkenstein 22
Palermo 22
Jinan 21
San Diego 21
Capaccio 20
Redondo Beach 20
São Paulo 20
Toronto 19
Guangzhou 18
Bengaluru 17
Chicago 17
Florence 17
Orem 17
Brussels 16
Munich 16
Phoenix 16
Modena 15
Yubileyny 15
Hebei 14
Shenyang 14
Vienna 14
Jiaxing 13
Redmond 13
Des Moines 12
Naples 12
Napoli 12
Pune 12
Saint Petersburg 12
Warsaw 12
London 11
Montreal 11
Shenzhen 11
Tianjin 11
Velletri 11
Bangkok 10
Bari 10
Changsha 10
Dearborn 10
Hải Dương 10
Jakarta 10
Johannesburg 10
Long Xuyen 10
Nuremberg 10
Paris 10
Perugia 10
Redwood City 10
Shanghai 10
Thái Nguyên 10
Bremen 9
Can Tho 9
Castel Maggiore 9
Genoa 9
Mumbai 9
Totale 6.333
Salva come PNG Salva come JPEG
Nome #
Polifenoli ed efficacia antinfiammatoria: lo strano caso del melograno e le malattie croniche intestinali 933
Risposta immunitaria verso Mycobacterium avium paratubercolosis (MAP) in pazienti affetti da Morbo di Crohn 384
Pomegranate: from the Promised Land to calm the fire in Inflammatory Bowel Disease 313
COVID-19 in IBD: The experience of a single tertiary IBD center 299
5-Aminosalicylic acid in patients with ulcerative colitis in remission: plasma levels after administration of a new rectal enema 266
Inflammation increases NOTCH1 activity via MMP9 and is counteracted by Eicosapentaenoic Acid-free fatty acid in colon cancer cells 262
Short-term treatment with eicosapentaenoic acid improves inflammation and affects colonic differentiation markers and microbiota in patients with ulcerative colitis 253
Can POSSUM accurately predict post-operative complications risk in patients with abdominal Crohn’s disease? 252
Clinical application of faecal calprotectin in ulcerative colitis patients 246
5-Aminosalicylic acid suppositories in the management of ulcerative colitis 239
Isolation of stem cell populations with trophic and immunoregulatory functions from human intestinal tissues: potential for cell therapy in inflammatory bowel disease. 235
Retention Rate, Persistence and Safety of Adalimumab in Inflammatory Bowel Disease: A Real-Life, 9-Year, Single-Center Experience in Italy 227
Intestinal epithelial cells in inflammatory bowel diseases 225
IL23R, NOD2/CARD15, ATG16L1 and PHOX2B polymorphisms in a group of patients with Crohn's disease and correlation with sub-phenotypes. 225
Pomegranate juice to reduce fecal calprotectin levels in inflammatory bowel disease patients with a high risk of clinical relapse: Study protocol for a randomized controlled trial 223
A Mediterranean Diet Mix Has Chemopreventive Effects in a Murine Model of Colorectal Cancer Modulating Apoptosis and the Gut Microbiota 223
New Insight and Knowledge on anti-inflammatory Effectiveness of dietary phenolics: a work-in-progress report of the NIKE Project 222
Eicosapentaenoic Acid Reduces Fecal Levels of Calprotectin and Prevents Relapse in Patients With Ulcerative Colitis 215
Highly Purified Eicosapentaenoic Acid as Free Fatty Acids Strongly Suppresses Polyps in ApcMin/+ Mice 205
Attachment and mentalizing abilities in patients with inflammatory bowel disease 203
Influence of steroid treatment's duration in patients with active Crohn's disease 203
Sulfasalazine in Prevention of Pouchitis After Proctocolectomy with Ileal Pouch–Anal Anastomosis for Ulcerative Colitis 196
Pilot study: the use of sulfasalazine for the treatment of acute pouchitis. 192
Mycobacterium avium subspecies paratuberculosis in the etiology of Crohn’s disease, cause or epiphenomenon? 188
Inflammatory bowel disease: Moving toward a stem cell-based therapy 185
Eicosapentaenoic acid free fatty acid prevents and suppresses colonic neoplasia in colitis-associated colorectal cancer acting on Notch signaling and gut microbiota 184
New proteomic approaches for biomarker discovery in inflammatory bowel disease 178
The Effect of Supplementing a Novel n-3 Polyunsaturated Fatty Acids Formulation Containing Schisandra chinensis Extract and Vitamin D3 to a Group of Elite Sport Athletes on Competition Related Stress, Anxiety and Self-confidence 177
Evidence for a Modulatory Effect of a 12‐Week Pomegranate Juice Intervention on the Transcriptional Response in Inflammatory Bowel Disease Patients Reducing Fecal Calprotectin Levels: Findings From a Proof‐of‐Principle Study 172
[Abdominal scintigraphy with leukocytes marked with indium-111 in Crohn disease: clinical importance and prognostic usefulness] 163
Aortic thrombosis recurrence in a Crohn's disease patient 160
New Insight and Knowledge on anti-inflammatory Effectiveness of dietary phenolics: the NIKE Project 159
A proposed staging system and stage-specific interventions for familial adenomatous polyposis 155
Eicosapentaenoic free fatty acid to treat patients with SARS-Cov2 infection 144
PROBABILISTIC ASSESSMENT OF SYMPTOMLESS INFLAMMATION IN CROHN’S DISEASE PATIENTS 143
null 139
p-ANCA and development of pouchitis in ulcerative colitis patients after proctocolectomy and ileoanal pouch anastomosis 124
Baseline Histological Findings Do Not Predict the Risk of Subsequent Extension in Patients with Limited Ulcerative Colitis 122
Effects of new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn's disease patients 115
Analysis of biological variables in Crohn's disease [4] 114
Bioavailability of single and multiple doses of a new oral formulation of 5‐ASA in patients with inflammatory bowel disease and healthy volunteers 105
Respiratory burst of circulating polymorphonuclear leukocytes and plasma elastase levels in patients with inflammatory bowel disease in remission 102
5-Aminosalicylic acid as enemas or suppositories in distal ulcerative colitis? 101
Optimum dosage of 5-Aminosalicylic acid as rectal enemas in patients with active ulcerative colitis 101
Interleukin 1 in ulcerative colitis 101
A combination of eicosapentaenoic acid-free fatty acid, epigallocatechin-3-gallate and proanthocyanidins has a strong effect on mTOR signaling in colorectal cancer cells. 100
Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion 100
Placebo-controlled trial of oral 5-ASA in relapse prevention of Crohn's disease 99
Scavenger effect of sulphasalazine (SASP), 5-aminosalicylic acid (5-ASA), and olsalazine (OAZ) (I) 97
Role of rectal formulations: Enemas 96
null 95
Enhanced mucosal interleukin-6 and -8 in Helicobacter pylori-positive dyspeptic patients 95
Macrophage subpopulations in pouchitis 95
Bronchopulmonary involvement in ulcerative colitis 92
Scavenger effect of sulfasalazine, 5-aminosalicylic acid, and olsalazine on superoxide radical generation 91
Short report: zinc sulphate supplementation corrects abnormal erythrocyte membrane long‐chain fatty acid composition in patients with Crohn's disease 90
Efficacy of 5-aminosalicylic acid enemas versus hydrocortisone enemas in ulcerative colitis 89
Topical treatment with 5-aminosalicylic in distal ulcerative colitis by using a new suppository preparation - A double-blind placebo controlled trial 88
Pentasa in maintenance treatment of ulcerative colitis 87
Interleukin 1 beta (IL-1 beta) release from fresh and cultured colonic mucosa in patients with ulcerative colitis (UC) 87
Requirements for the use of intestinal action antibiotics in the treatment of ulcerative colitis 86
MRI patterns in a case of 6-thioguanine-related hepatic sinusoidal obstruction syndrome 85
Steroid treatment in active Crohn's disease: a comparison between two regimens of different duration 82
Mucosal concentrations of interleukin-1β, interleukin-6, interleukin-8, and tumor necrosis factor-α in pelvic ileal pouches 82
Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis 76
Affective EEG Decoding Generalizes Across Colormap and Exposure Time 41
Totale 11.226
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.114
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.114
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021316 0 0 0 0 0 0 0 0 0 48 69 199
2021/20221.230 42 42 58 95 83 47 41 51 129 106 349 187
2022/20231.608 146 248 121 176 95 125 70 106 280 43 103 95
2023/2024584 43 70 64 56 58 107 37 32 29 48 19 21
2024/20251.849 111 210 142 112 295 98 173 90 46 131 92 349
2025/20263.586 403 299 295 269 362 222 376 168 917 275 0 0
Totale 11.226